PSEN1 and Alzheimer disease: A number of studies have assessed the impact of adaptive immunity on disease progression in several early-onset AD (EOAD) transgenic (Tg) mouse models, which overexpress the Amyloid precursor protein (APP) and presenilin 1 (PS1) proteins.